ckd-508
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 26, 2020 (NCT04488900)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
NCEH1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06979973 | Phase 1 | May 14, 2025 | Chong Kun Dang Pharmaceutical |
| NCT06727396 | Phase 1 | Nov 14, 2024 | Chong Kun Dang Pharmaceutical |
| NCT04488900 | Phase 1 | Jul 26, 2020 | Chong Kun Dang Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 3 | 3 | 1 | 2020 |
1 organizations
Page 1 / 1